E-Liquid clinical trials at University of California Health

1 research study open to eligible people

Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
open to eligible people ages 21-70
This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.
at UCSF

Our lead scientists for E-Liquid research studies include Neal L Benowitz, MD.

Last updated: May 3, 2022

Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes